Evidence map›Paper›PMID 42087501›Full record

ArticleRapid communications in mass spectrometry : RCM2026

Characterization of Grape Cane Stilbenoids and Their Photo-Degradation Products by HPLC-DAD Coupled With Trapped Ion Mobility Spectrometry and High-Resolution Tandem Mass Spectrometry.

Paul Besrukow, Friederike A Schnitker, Ralf Schweiggert, Christof B Steingass

Abstract read
In one paragraph

Article in Rapid communications in mass spectrometry : RCM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paul BesrukowDepartment of Beverage Research, Geisenheim University, Geisenheim, Germany.ORCID https://orcid.org/0000-0001-5123-9474
Friederike A SchnitkerDepartment of Beverage Research, Geisenheim University, Geisenheim, Germany.
Ralf SchweiggertDepartment of Beverage Research, Geisenheim University, Geisenheim, Germany.
Christof B SteingassDepartment of Beverage Research, Geisenheim University, Geisenheim, Germany.

Funding

Federal Ministry of Food and Agriculture 2818OE004
6 · The paper itself

Abstract

rationaleBioactive (E)-stilbenoids in vine extracts are prone to light-induced transformation into the respective (Z)-isomers and further degradation products, often resulting in a loss of bioactivity. We sought to study stilbenoid degradation beyond that of the well-researched resveratrol due to the high diversity of stilbenoids in nature.

methodsNine authentic, individual stilbenoids and a stilbenoid-rich grape cane extract were irradiated with artificial sunlight and their photodegradation products analyzed by liquid chromatography coupled with diode array detection, electrospray ionization, trapped ion mobility spectrometry, and quadrupole time-of-flight high-resolution tandem mass spectrometry (HPLC-DAD-ESI-TIMS-QTOF-HR-MS/MS).

resultsOverall, a total of 45 different transformation products were identified in light-exposed standard solutions and the grape cane extract. For the first time, collision cross section values of grape cane stilbenoids (154.8-286.4 Å

conclusionThese results highlight the potential of combining liquid chromatography, TIMS, and HR-MS/MS for these types of compounds to broaden the knowledge on photodegradation pathways of grapevine stilbenoids beyond resveratrol.

Indexed as

Plant ExtractsStilbenesTandem Mass SpectrometryVitisChromatography, High Pressure LiquidIon Mobility SpectrometryPhotolysisSpectrometry, Mass, Electrospray IonizationPlant ExtractsStilbenesCCSlightresveratrolTIMSviticulture

Identifiers

PMID42087501
PMCPMC13145325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.